Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Return on Invested Capital (2016 - 2025)

Altimmune (ALT) has disclosed Return on Invested Capital for 12 consecutive years, with 0.48% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital changed N/A to 0.48% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.48%, a N/A change, with the full-year FY2022 number at 0.45%, changed N/A from a year prior.
  • Return on Invested Capital was 0.48% for Q3 2025 at Altimmune, up from 0.59% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.21% in Q1 2021 to a low of 0.73% in Q1 2025.
  • A 3-year average of 0.44% and a median of 0.45% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: surged 39bps in 2021, then fell -7bps in 2022.
  • Altimmune's Return on Invested Capital stood at 0.37% in 2021, then fell by -21bps to 0.45% in 2022, then dropped by -6bps to 0.48% in 2025.
  • Per Business Quant, the three most recent readings for ALT's Return on Invested Capital are 0.48% (Q3 2025), 0.59% (Q2 2025), and 0.73% (Q1 2025).